EVE HOLDING INC (EVEX) Fundamental Analysis & Valuation

NYSE:EVEXUS29970N1046

Current stock price

2.7 USD
+0.04 (+1.5%)
At close:
2.738 USD
+0.04 (+1.41%)
After Hours:

This EVEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EVEX Profitability Analysis

1.1 Basic Checks

  • EVEX had negative earnings in the past year.
  • In the past year EVEX has reported a negative cash flow from operations.
  • In the past 5 years EVEX always reported negative net income.
  • EVEX had a negative operating cash flow in each of the past 5 years.
EVEX Yearly Net Income VS EBIT VS OCF VS FCFEVEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M -200M

1.2 Ratios

  • With a Return On Assets value of -51.57%, EVEX is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
  • The Return On Equity of EVEX (-181.20%) is worse than 90.00% of its industry peers.
Industry RankSector Rank
ROA -51.57%
ROE -181.2%
ROIC N/A
ROA(3y)-49.01%
ROA(5y)-61.27%
ROE(3y)-123.35%
ROE(5y)-110.37%
ROIC(3y)N/A
ROIC(5y)N/A
EVEX Yearly ROA, ROE, ROICEVEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EVEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVEX Yearly Profit, Operating, Gross MarginsEVEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

3

2. EVEX Health Analysis

2.1 Basic Checks

  • EVEX has more shares outstanding than it did 1 year ago.
  • EVEX has more shares outstanding than it did 5 years ago.
  • EVEX has a better debt/assets ratio than last year.
EVEX Yearly Shares OutstandingEVEX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
EVEX Yearly Total Debt VS Total AssetsEVEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • EVEX has an Altman-Z score of -1.38. This is a bad value and indicates that EVEX is not financially healthy and even has some risk of bankruptcy.
  • EVEX has a Altman-Z score of -1.38. This is amonst the worse of the industry: EVEX underperforms 87.50% of its industry peers.
  • EVEX has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of EVEX (1.43) is worse than 78.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z -1.38
ROIC/WACCN/A
WACCN/A
EVEX Yearly LT Debt VS Equity VS FCFEVEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • EVEX has a Current Ratio of 3.29. This indicates that EVEX is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 3.29, EVEX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • A Quick Ratio of 3.29 indicates that EVEX has no problem at all paying its short term obligations.
  • The Quick ratio of EVEX (3.29) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 3.29
EVEX Yearly Current Assets VS Current LiabilitesEVEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

0

3. EVEX Growth Analysis

3.1 Past

  • EVEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.38%.
EPS 1Y (TTM)-44.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • EVEX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.76% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.72%
EPS Next 2Y1.18%
EPS Next 3Y10.52%
EPS Next 5Y5.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVEX Yearly Revenue VS EstimatesEVEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EVEX Yearly EPS VS EstimatesEVEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.2 -0.2 0.4 -0.4 -0.6

0

4. EVEX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for EVEX. In the last year negative earnings were reported.
  • Also next year EVEX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVEX Price Earnings VS Forward Price EarningsEVEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVEX Per share dataEVEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.18%
EPS Next 3Y10.52%

0

5. EVEX Dividend Analysis

5.1 Amount

  • EVEX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EVEX Fundamentals: All Metrics, Ratios and Statistics

EVE HOLDING INC

NYSE:EVEX (4/10/2026, 8:19:44 PM)

After market: 2.738 +0.04 (+1.41%)

2.7

+0.04 (+1.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-16
Earnings (Next)05-11
Inst Owners12.15%
Inst Owner Change0%
Ins Owners0.29%
Ins Owner Change0%
Market Cap940.41M
Revenue(TTM)N/A
Net Income(TTM)-224.25M
Analysts78.67
Price Target7.17 (165.56%)
Short Float %6.47%
Short Ratio4.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.59%
Min EPS beat(2)-13.12%
Max EPS beat(2)16.31%
EPS beat(4)1
Avg EPS beat(4)-8.65%
Min EPS beat(4)-27.33%
Max EPS beat(4)16.31%
EPS beat(8)5
Avg EPS beat(8)4.01%
EPS beat(12)9
Avg EPS beat(12)9.2%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.05%
PT rev (3m)-2.2%
EPS NQ rev (1m)-5.81%
EPS NQ rev (3m)-2.5%
EPS NY rev (1m)-6.21%
EPS NY rev (3m)-11.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)38.32%
Revenue NY rev (3m)26.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.6
P/tB 7.6
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.7
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -51.57%
ROE -181.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-49.01%
ROA(5y)-61.27%
ROE(3y)-123.35%
ROE(5y)-110.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1584.41%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 3.29
Altman-Z -1.38
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)1233.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.57%
EPS Next Y-0.72%
EPS Next 2Y1.18%
EPS Next 3Y10.52%
EPS Next 5Y5.76%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-44.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.63%
EBIT Next 3Y12.72%
EBIT Next 5Y24.58%
FCF growth 1Y-24.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-18%
OCF growth 3YN/A
OCF growth 5YN/A

EVE HOLDING INC / EVEX Fundamental Analysis FAQ

What is the fundamental rating for EVEX stock?

ChartMill assigns a fundamental rating of 1 / 10 to EVEX.


What is the valuation status for EVEX stock?

ChartMill assigns a valuation rating of 0 / 10 to EVE HOLDING INC (EVEX). This can be considered as Overvalued.


What is the profitability of EVEX stock?

EVE HOLDING INC (EVEX) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for EVEX stock?

The Earnings per Share (EPS) of EVE HOLDING INC (EVEX) is expected to decline by -0.72% in the next year.